IPCA Laboratories Q4 Results Live : profit falls by 22.12% YOY

IPCA Laboratories Q4 Results Live : IPCA Laboratories announced their Q4 results on 29 May, 2024. The company reported a 34.49% increase in revenue year-over-year, but saw a 22.12% decrease in profit compared to the same period last year.

Quarterly comparisons show a 0.97% decline in revenue and a significant 66.87% decrease in profit from the previous quarter.

Selling, general & administrative expenses went up by 1.52% sequentially and by 42.37% year-over-year.

Operating income took a hit, declining by 62.45% quarter-over-quarter and 21.93% year-over-year.

The earnings per share (EPS) for Q4 stood at ₹5.85, marking a 94.06% increase from the previous year.

In terms of market performance, IPCA Laboratories delivered -1.86% return in the last week, 15.45% return in the last 6 months, and a YTD return of 16.25%.

The company currently boasts a market capitalization of ₹32,829.33 Cr, with a 52-week high/low of ₹1374.6 & ₹685.8 respectively.

Analysts covering IPCA Laboratories have mixed opinions, with 3 analysts rating it as Strong Sell, 2 as Sell, 3 as Hold, 4 as Buy, and 2 as Strong Buy. The consensus recommendation as of 30 May, 2024, was to Hold.